These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23224908)

  • 1. Taurine and atherosclerosis.
    Murakami S
    Amino Acids; 2014 Jan; 46(1):73-80. PubMed ID: 23224908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation.
    Murakami S; Sakurai T; Tomoike H; Sakono M; Nasu T; Fukuda N
    Amino Acids; 2010 Jan; 38(1):271-8. PubMed ID: 19229588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of chronic hyperlipidemia on bladder function in myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHLMI) rabbits.
    Yoshida M; Masunaga K; Nagata T; Satoji Y; Shiomi M
    Neurourol Urodyn; 2010 Sep; 29(7):1350-4. PubMed ID: 20127840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits with mesenteric fat accumulation are a novel animal model for metabolic syndrome.
    Shiomi M; Kobayashi T; Kuniyoshi N; Yamada S; Ito T
    Pathobiology; 2012; 79(6):329-38. PubMed ID: 22688430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction following atherosclerosis in murine models.
    Braun A; Rigotti A; Trigatti BL
    Curr Drug Targets; 2008 Mar; 9(3):217-23. PubMed ID: 18336240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of taurine in the pathogenesis of obesity.
    Murakami S
    Mol Nutr Food Res; 2015 Jul; 59(7):1353-63. PubMed ID: 25787113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of atherosclerosis.
    Fuster JJ; Castillo AI; Zaragoza C; Ibáñez B; Andrés V
    Prog Mol Biol Transl Sci; 2012; 105():1-23. PubMed ID: 22137427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlipidaemia and cardiovascular disease: oxidative damage and atherosclerosis.
    Le NA
    Curr Opin Lipidol; 2006 Feb; 17(1):92-4. PubMed ID: 16407721
    [No Abstract]   [Full Text] [Related]  

  • 9. [Increased myocardial expression of calcium-sensing receptor and apoptosis in a rat model of atherosclerosis].
    GUO J; XU CQ; LI HZ; WANG LN; Wang LC; ZHANG L; ZHANG WH; LI GW; TIAN Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1101-5. PubMed ID: 19134279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number-needed-to-treat analysis of the prevention of myocardial infarction and death by antidyslipidemic therapy.
    Rembold CM
    J Fam Pract; 1996 Jun; 42(6):577-86. PubMed ID: 8656168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is taurine a functional nutrient?
    Bouckenooghe T; Remacle C; Reusens B
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):728-33. PubMed ID: 17053427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit).
    Shiomi M; Ito T; Yamada S; Kawashima S; Fan J
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1239-44. PubMed ID: 12738683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis.
    Russell JC; Proctor SD
    Cardiovasc Pathol; 2006; 15(6):318-30. PubMed ID: 17113010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model.
    Hasty AH; Gruen ML; Terry ES; Surmi BK; Atkinson RD; Gao L; Morrow JD
    J Nutr Biochem; 2007 Feb; 18(2):127-33. PubMed ID: 16781857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia and cardiovascular disease.
    Malloy MJ; Kane JP
    Curr Opin Lipidol; 2012 Dec; 23(6):591-2. PubMed ID: 23160407
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-atherosclerotic effects of peptidic geroprotector].
    Ryzhak AP; Kuznik BI; Putkovskaia VN; Ryzhak GA
    Adv Gerontol; 2012; 25(1):139-42. PubMed ID: 22708459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of insulin growth factor on atherosclerosis and endothelial function: the effect on hyperlipidemia and aging.
    Hirai H; Kanaya R; Maeda M; Qungfang D; Ina K; Hayashi T
    Life Sci; 2011 Feb; 88(9-10):425-31. PubMed ID: 21219916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurine in cardiovascular disease.
    Zulli A
    Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):57-60. PubMed ID: 21076292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.